Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of topiramate on clinical and electrophysiological parameters in subjects with diabetic peripheral polyneuropathy has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetic Neuropathies, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED